Clinical Trials Directory

Trials / Completed

CompletedNCT03688542

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Anne Niquille · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments. The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.

Conditions

Interventions

TypeNameDescription
OTHERQuality Circle Deprescribing ModuleThe Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..

Timeline

Start date
2017-09-25
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2018-09-28
Last updated
2021-04-21
Results posted
2021-04-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03688542. Inclusion in this directory is not an endorsement.

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module (NCT03688542) · Clinical Trials Directory